Schrodinger, Inc.
Schrodinger, Inc. (SDGR) is listed on NASDAQ and classified in Health Information Services, part of the Healthcare sector. It is headquartered in New York, United States and has 850 employees. The company is worth $1.69B. Revenue was $255.87M in fiscal 2025, up 23.3% from the year before. It reported a net loss of $103.27M. The share price is 33.1% below its 52-week high of $33.78. 4 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Bill Gates (Gates Foundation Trust), at $113.45M. In that quarter, 2 of them opened or added to the position and 1 reduced it. No open-market insider trades in it were filed over the last 30 days.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Articles on this site that cover Schrodinger, Inc..
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Major managers that reported this stock in their latest 13F.
▼ -42.3% over 5Y.
today you would have $414.07▼ -58.6%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 6 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Year-end price | $17.88 | $19.29 | $35.80 | $18.69 | $34.83 | $79.18 | |
| P/E | — | — | — | 66.3x | — | — | — |
| P/S | 8.6x | 5.1x | 6.8x | 10.4x | 6.4x | 15.6x | 44.5x |
| P/B | 3.7x | 3.6x | 3.3x | 4.1x |
Seven formulas applied to the reported numbers, each with its assumption next to the result. None of them predicts a price.
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Cash flow growing 5.0% a year for 10 years, discounted at 10%, then 2.5% forever.
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| PSNLPersonalis, Inc. | $15.82 | — | 7.2x | 0.00% | -50.32% | $1.69B |
| OMCLOmnicell Inc | $37.10 | 43.1x | 1.3x | 0.00% | 3.06% | $1.69B |
| ANIPAni Pharmaceuticals Inc | $73.75 | 16.0x | 2.6x | 0.00% | 20.46% | $1.69B |
| SNDASonida Senior Living Inc | $35.29 |
| 2.6x |
| 3.9x |
| 7.7x |
| EPS | -$1.41 | -$2.57 | $0.54 | -$2.10 | -$1.42 | -$0.41 |
| Profit margin | -56.57% | -40.36% | -90.16% | 18.79% | -82.44% | -72.78% | -22.63% |
| ROE | -23.19% | -28.37% | -44.40% | 7.42% | -33.31% | -18.02% | -3.92% |
Median of the years shown; P/E years above 200x are left out.
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
The average of the method families that answered, not of the seven numbers: four of the seven start from the same earnings per share.
1 methods answered, across 1 families.
Room for errors in the reported numbers.
-73.8% from the average.
Models, not forecasts, and not investment advice. How each formula works →
| — |
| 1.9x |
| 0.00% |
| -25.24% |
| $1.7B |
| BRVEBraveheart Bio, Inc. | $18.71 | — | — | 0.00% | — | $1.68B |
| SEPNSepterna, Inc. | $36.35 | — | 4.3x | 0.00% | -6.34% | $1.7B |